Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2011 1
2012 10
2013 79
2014 123
2015 153
2016 149
2017 127
2018 134
2019 128
2020 115
2021 41
Text availability
Article attribute
Article type
Publication date

Search Results

897 results
Results by year
Filters applied: . Clear all
Page 1
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
Deshpande D, Pasipanodya JG, Mpagama SG, Bendet P, Srivastava S, Koeuth T, Lee PS, Bhavnani SM, Ambrose PG, Thwaites G, Heysell SK, Gumbo T. Deshpande D, et al. Clin Infect Dis. 2018 Nov 28;67(suppl_3):S293-S302. doi: 10.1093/cid/ciy611. Clin Infect Dis. 2018. PMID: 30496461 Free PMC article.
An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency.
Bennett AC, Bennett CL, Witherspoon BJ, Knopf KB. Bennett AC, et al. Expert Opin Drug Saf. 2019 Nov;18(11):1055-1063. doi: 10.1080/14740338.2019.1665022. Epub 2019 Sep 18. Expert Opin Drug Saf. 2019. PMID: 31500468 Review.
897 results